Contents:

1. Research Scope and Methodology -1. Scope and Segmentation --1. Research Scope --2. Market Segmentation -2. Methodology --1. Methodology --2. Key Definitions 2. Clinical Laboratory Instrumentation Market in Singapore -1. Market Overview --1. Introduction --2. Market Engineering Measurements -2. Market Dynamics --1. Industry Challenges --2. Market Drivers a. Greater Funding Options Drives Upgrading and Replacement of Systems b. Singapore is a Technological Showcase for the Rest of Asia Pacific c. Investment in Automation Increases Productivity and Reduces Labour Costs --3. Market Restraints a. Lease-based Agreements to Ensure Instrument Placement Have Eroded Profit Margins from Analyzer Sales b. End-user Mentalities Create Bureaucratic Hurdles to Effective Implementation of Automation Across All Segments 3. Market Forecasts and Technology Trends -1. Market Forecasts --1. Total Revenue Forecasts --2. Clinical Chemistry Revenue Forecasts --3. Immunochemistry Revenue Forecasts --4. Hematology Revenue Forecasts --5. Urinalysis Revenue Forecasts --6. Molecular Diagnostics Revenue Forecasts --7. Product Segment Life Cycle -2. Technology Trends --1. Integrated Analyzers --2. Total Laboratory Automation 4. Competitive Analysis -1. Competitive Structure --1. Competitive Structure -2. Competitive Landscape --1. Clinical Chemistry --2. Immunochemistry --3. Hematology --4. Urinalysis --5. Molecular Diagnostics 5. Strategic Recommendations -1. Strategic Recommendations --1. Promote Total Laboratory Automation and Modular Automation --2. Focus on Service Quality and Maintain Good Customer Relations 6. Decision Support Databases -1. Demography --1. Total Healthcare Expenditure --2. Per Capita Healthcare Expenditure --3. Population Over 65 List of Figures - Clinical Laboratory Instrumentation Market: Impact of Key Industry Challenges (Singapore), 2006-2010 - Clinical Laboratory Instrumentation Market: Market Drivers Ranked in Order of Impact (Singapore), 2006-2010 - Clinical Laboratory Instrumentation Market: Market Restraints Ranked in Order of Impact (Singapore), 2006-2010 - Clinical Laboratory Instrumentation Market: Database of Key Industry Participants by Product Type (Singapore), 2006 - Total Clinical Laboratory Instrumentation Market: Revenue Forecasts (Singapore), 2006-2010 - Clinical Laboratory Instrumentation Market: Revenue Forecasts for Clinical Chemistry Analyzers (Singapore), 2005-2010 - Clinical Laboratory Instrumentation Market: Revenue Forecasts for Immunochemistry Analyzers (Singapore), 2005-2010 - Clinical Laboratory Instrumentation Market: Revenue Forecasts for Hematology Analyzers (Singapore), 2005-2010 - Clinical Laboratory Instrumentation Market: Revenue Forecasts for Urinalysis Analyzers (Singapore), 2005-2010 - Clinical Laboratory Instrumentation Market: Revenue Forecasts for Molecular Diagnostic Analyzers (Singapore), 2005-2010 - Clinical Laboratory Instrumentation Market: Competitive Structure (Singapore), 2005 - Clinical Chemistry Analyzer Market: Products Offered by Major Market Participants (Singapore), 2005 - Immunochemistry Analyzer Market: Products Offered by Major Market Participants (Singapore), 2005 - Hematology Analyzer Market: Products Offered by Major Market Participants (Singapore), 2005 - Urinalysis Analyzer Market: Products Offered by Major Market Participants (Singapore), 2005 - Molecular Diagnostic Analyzers Market: Products Offered by Major Market Participants (Singapore), 2005

Summary:

Strong Funding Drives Significant Investment in Clinical Laboratory Instrumentation in Singapore Public demand for superior healthcare combined with a rise in infectious and chronic diseases and an increasingly affluent population has contributed to significant growth of in-vitro diagnostics (IVD) in the Asia Pacific. This, in turn, has driven strong penetration of automated clinical laboratory analyzers in the region, particularly in advanced markets such as Singapore, Taiwan and Korea. While these markets are now approaching maturity, they are nevertheless well positioned for greater automation with the introduction of integrated systems, modular and total laboratory automation. "The Singaporean market represents an ideal platform for the implementation of modular and total laboratory automation solutions," remarks the analyst of this research service. "Total laboratory automation solutions allow hospitals to enhance productivity and deal with higher testing volumes, while significantly increasing turn-around-time (TAT), all of which are key factors in raising penetration rates of these solutions in Singapore." High levels of healthcare funding, both in the private and public sectors is a key factor driving investment in new automation technology in Singapore. Hospitals are compelled to use their healthcare budgets completely within each fiscal year, allowing them considerable flexibility to upgrade or add to their current systems. The demand for diagnostic tests is expected to continue being high in both public and private healthcare sectors, with volumes likely to increase at an average of 10 percent per year. With the introduction of new assays and consolidated systems, this is likely to continue driving the upgrading and replacement of existing systems. Singapore’s Position as a Technological Leader to Promote Short-term Market Growth While the clinical laboratory instrumentation market in Singapore is one of the most advanced in the Asia Pacific, it is also among the more mature ones and is characterized by a small installed base. Moreover, despite the fact that there is no lack of funds for the healthcare sector, the growing preference for lease-based agreements and reagent rental contracts rather than outright purchases has caused a dip in the profits earned from clinical laboratory instrumentation sales. "Nonetheless, Singapore remains a key region in the Asia Pacific clinical laboratory instrumentation market, as many manufacturers utilize it as a base to showcase sophisticated products such as total laboratory automation, to the rest of the region," says the analyst. Many countries consider Singapore a benchmark and use it as a model for developing their own healthcare infrastructure. However, since there are a limited number of manufacturers capable of offering total laboratory automation options, this factor is expected to have an impact on market growth only during the short term.